Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 847.80
Bid: 849.60
Ask: 850.00
Change: 6.80 (0.81%)
Spread: 0.40 (0.047%)
Open: 841.60
High: 852.80
Low: 841.00
Prev. Close: 841.00
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 May 2018 13:52

RNS Number : 3717P
Informa PLC
25 May 2018
 

Informa LEI: 5493006VM2LKUPSEDU20

Press Release

25 May 2018

Informa PLC

Results of Annual General Meeting

London: Informa PLC (the "Company"), the international Exhibitions, Events, Business Intelligence and Academic Publishing Group, announces that at today's Annual General Meeting (the "AGM"), all resolutions were passed on a poll.

The full results are set out in the table below. In accordance with Listing Rule 9.6.3R, copies of resolutions other than those concerning ordinary business passed at the AGM, have been submitted to the National Storage Mechanism and will be available in due course for viewing at www.hemscott.com/nsm.do.

 

 

RESOLUTION

FOR1

AGAINST

TOTAL

WITHHELD2

 

 

Votes

%

Votes

%

Votes

Votes

1

Receive the annual report for the year ended 31 December 2017

668,459,284

99.93

476,691

0.07

668,935,975

5,962,925

2

To declare a final dividend of 13.8 pence per ordinary share

674,131,678

100.00

946

0.00

674,132,624

766,277

3

Approve the Directors' Remuneration Policy

426,506,481

64.19

237,979,957

35.81

664,486,438

10,412,463

4

Approve the Directors' Remuneration Report

628,334,895

93.21

45,796,471

6.79

674,131,366

767,534

5

Re-elect Derek Mapp as a Director

518,572,682

85.38

88,782,174

14.62

607,354,856

67,544,043

6

Re-elect Stephen A Carter as a Director

674,129,982

100.00

1,965

0.00

674,131,947

766,954

7

Re-elect Gareth Wright as a Director

674,006,156

99.98

111,298

0.02

674,117,454

781,447

8

Re-elect Gareth Bullock as a Director

663,710,408

98.45

10,421,539

1.55

674,131,947

766,954

9

Re-elect Cindy Rose as a Director

667,434,912

99.01

6,697,034

0.99

674,131,946

766,954

10

Re-elect Helen Owers as a Director

659,747,210

97.87

14,384,736

2.13

674,131,946

766,954

11

Re-elect Stephen Davidson as a Director

592,828,822

90.66

61,085,346

9.34

653,914,168

20,984,731

12

Re-elect David Flaschen as a Director

674,126,786

100.00

5,161

0.00

674,131,947

766,954

13

Re-elect John Rishton as a Director

673,258,195

99.87

873,752

0.13

674,131,947

766,954

14

Re-appoint Deloitte LLP as auditor of the Company

660,888,020

98.04

13,241,634

1.96

674,129,654

769,246

15

Authorise the Audit Committee (on behalf of the Directors) to determine the remuneration of the auditor

670,240,861

99.42

3,891,142

0.58

674,132,003

766,898

16

Authorise the Company to make political donations and expenditure

670,080,487

99.40

4,032,567

0.60

674,113,054

785,847

17

Authorise the Directors to allot shares

644,645,254

95.53

30,188,138

4.47

674,833,392

65,509

18

Approve amendments to the Informa 2014 Long-Term Incentive Plan

466,662,510

69.45

205,278,687

30.55

671,941,197

2,957,704

19

Approve the Informa 2017 U.S. Employee Stock Purchase Plan

674,673,470

99.97

183,475

0.03

674,856,945

41,956

20

To approve an increase in the aggregate sum that may be paid as Non-Executive Director's fees from £1,000 000 to £1,500,000

667,656,049

99.04

6,451,207

0.96

674,107,256

791,644

21

To authorise the Directors to disapply statutory pre-emption rights in respect of 5% of the Company's issued share capital

661,430,599

99.70

1,971,593

0.30

663,402,192

11,496,709

22

To authorise the Directors to disapply statutory pre-emption rights in respect of an additional 5% of the Company's issued share capital

634,737,491

95.68

28,664,846

4.32

663,402,337

11,496,563

23

Authorise the Company to purchase its own shares

666,975,135

99.06

6,332,382

0.94

673,307,517

1,591,383

24

Authorise the Directors to call general meetings (other than AGMs) on not less than 14 clear days' notice

657,239,895

97.49

16,892,131

2.51

674,132,026

766,875

 

Notes:

1. Any proxy appointments which gave discretion to the Chairman have been included in the "for" total

2. A 'Vote Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes 'for' and 'against' a resolution.

Following the strong support received by shareholders at the recent General Meeting to approve the Offer for UBM plc, the Board is pleased that shareholders also voted in support of all resolutions at today's Annual General Meeting. As part of this, we note that shareholders approved our new Remuneration Policy, which was updated following an extensive and detailed round of shareholder consultation and engagement. We also recognise that a minority of shareholders voted against Resolution 3, albeit for a variety of different reasons. The Board and the Remuneration Committee believes that the updated Policy is closely aligned with shareholders' interests and key to supporting the Company's strategy following the combination with UBM plc. Notwithstanding this, the Remuneration Committee notes the various issues raised by some shareholders and will reflect on the feedback received.

Enquiries

 

Informa PLC

 

Rupert Hopley, Group Company Secretary

+44 (0) 20 7017 5000

Richard Menzies-Gow, Director of Investor Relations

+44 (0) 20 3377 3445

Notes to editors

About Informa PLC

Informa operates at the heart of the Knowledge and Information Economy. It is one of the world's leading business intelligence, academic publishing, knowledge and events businesses.

With more than 7,500 colleagues globally, it has a presence in all major geographies, including North America, South America, Asia, Europe, the Middle East and Africa.

To learn more, please visit www.informa.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGLLFEFELIEFIT
Date   Source Headline
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSInforma Share Buyback Programme
15th Mar 20225:53 pmRNSHolding(s) in Company
15th Mar 20225:35 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNS2021 Full Year Results Statement
15th Mar 20227:00 amRNSHolding(s) in Company
8th Mar 20227:00 amRNSInforma Share Buyback Programme
7th Mar 20227:00 amRNSInforma Share Buyback Programme
4th Mar 20227:00 amRNSInforma Share Buyback Programme
3rd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSTotal Voting Rights
1st Mar 20227:00 amRNSInforma Share Buyback Programme
28th Feb 20227:00 amRNSInforma Share Buyback Programme
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSInforma Share Buyback Programme
23rd Feb 20227:00 amRNSInforma Share Buyback Programme
22nd Feb 20227:00 amRNSInforma Share Buyback Programme
21st Feb 20225:34 pmRNSHolding(s) in Company
21st Feb 20225:29 pmRNSHolding(s) in Company
21st Feb 20227:55 amRNSInforma Share Buyback Programme
18th Feb 20227:00 amRNSInforma Share Buyback Programme
17th Feb 20227:00 amRNSInforma Share Buyback Programme
16th Feb 202211:18 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSInforma Share Buyback Programme
15th Feb 20227:00 amRNSInforma Share Buyback Programme
10th Feb 20228:10 amRNSDivestment of Pharma Intelligence for £1.9bn
4th Feb 20226:03 pmRNSBlock listing Interim Review
4th Feb 20224:03 pmRNSNotice of Results
1st Feb 20224:17 pmRNSHolding(s) in Company
20th Jan 20224:58 pmRNSHolding(s) in Company
13th Jan 20225:40 pmRNSBoard Update
13th Jan 20227:00 amRNSHolding(s) in Company
12th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20225:52 pmRNSHolding(s) in Company
12th Jan 20225:51 pmRNSHolding(s) in Company
17th Dec 20212:16 pmRNSDirector/PDMR Shareholding
14th Dec 202110:53 amRNSHolding(s) in Company
14th Dec 202110:19 amRNSDirector/PDMR Shareholding
7th Dec 202112:00 pmRNSCapital Markets Day - Growth Acceleration Plan II
26th Nov 20213:32 pmRNSHolding(s) in Company
26th Nov 20213:27 pmRNSHolding(s) in Company
17th Nov 20217:00 amRNSTrading Statement & Board Update
1st Oct 20217:00 amRNSBoard Update
5th Aug 20216:19 pmRNSBlock listing Interim Review
5th Aug 20216:07 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNS2021 Half Year Results Statement
3rd Jun 20215:16 pmRNSResult of AGM
3rd Jun 20217:00 amRNSTrading Update
2nd Jun 20214:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.